Stay updated on Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the page's documentation/versioning. This update does not alter study details or other substantive content presented on the page.SummaryDifference0.1%

- Check20 days agoChange DetectedThe revision label on the page updated from v3.6.0 to v3.6.2, indicating a newer page version. This reflects a backend or frontend adjustment rather than changes to the study data.SummaryDifference0.1%

- Check34 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a No longer looking for participants notice indicating enrollment has ended. The label for the Intervention/Treatment section was updated (from Intervention / Treatment), and the revision version changed from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page revision label updated from v3.5.4 to v3.5.5, indicating a small internal update that does not alter the study content or user-facing information.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous revision label. This reflects a new release/version of the study record display.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision label, Revision: v3.5.3, was added, and the previous Revision: v3.5.2 label was removed, updating the page's version history.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.